Register information Protection certificate

DE file number : 12 2020 000 079.5 (Status: pending/in force, Query started: May 29, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTPending/in force
21DE file number DAKZ12 2020 000 079.5
UseVZMedicinal products
95Product nameTIEZCalcifediol und/oder pharmazeutisch akzeptable Salze und Hydrate davon, bevorzugt Calcifediolmonohydrat
54Title of basic patentTIGZOrale Zusammensetzungen mit kontrollierter Freisetzung mit einer Vitamin-D-Verbindung und einem wachsartigen Träger
51IPC main classICM
(ICMV)		 A61K 9/48 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 31/593 (2006.01), A61K 47/06 (2006.01), A61K 47/14 (2006.01), A61K 47/44 (2017.01)
94Start of term of protectionLBApr 26, 2028
22DE application dateDATDec 11, 2020
Date of publication of application for a certificateOTMar 18, 2021
71/73Applicant/ownerINHEirGen Pharma Ltd., Old Kilmeaden Road, X91 YV67 Waterford, IE; Opko Renal, LLC, 4400 Biscayne Blvd., 33137 Miami, FL, US
74RepresentativeVTRMeissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB, 80538 München, DE
Address for service Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB, 81633 München, DE
Patent division in charge 44
68DE file number of basic patentGAKZ60 2008 032 921.6
68EP file number of basic patentGEAKZ12 15 4573.5
43Date of first publicationEVTMar 18, 2021
92
92
92
Domestic authorisationGIS
GIN
GIT
Bundesinstitut für Arzneimittel und Medizinprodukte
2202115.00.00
2020-08-18
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Medicines & Healthcare products Regulatory Agency
Vereinigtes Königreich Großbritannien und Nordirland
PL 50784/0005 - 0001
2020-07-21
Date of the first transfer into DPMAregisterEREGTMar 18, 2021
Date of the (most recent) update in DPMAregisterREGTAug 19, 2024
(Show all update days)(Hide all update days)
  • Aug 19, 2024
    • St.36: changed (technical change)
  • Apr 7, 2022
    • Historical data not available for this/these date(s)
  • Mar 18, 2021
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed Feb 9, 2021 Mar 18, 2021 Details anzeigen
2 New applicant/owner details New applicant/owner details Apr 6, 2022  Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTFeb 9, 2021
Issue numberHN11
YearPJ2021
Publication dateVTMar 18, 2021
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ60 2008 032 921.6
68EP file number of basic patentGEAKZ12 15 4573.5
Date of update of the procedureREGTMar 18, 2021
View procedures New applicant/owner details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTApr 6, 2022
71/73Applicant/ownerINHEirGen Pharma Ltd., X91 YV67 Waterford, IE; Opko Renal, LLC, 33137 Miami, FL, US
71/73Previous applicant/ownerINHFOpko Ireland Global Holdings, Ltd., Dublin 24, IE, Opko Renal, LLC, Miami, FL 33137, US
Date of update of the procedureREGTApr 7, 2022